G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Field Service Engineer 2

Full-TimePosted on 10/19/2026
$105.1k - $157.7k/yr+ Performance-based cash bonus(es) + Long-term incentives
Mid
Bachelor's, Associate's
Remote in USA+1 moreMore locations: Fresno, CA, USA
RemoteATS lists remote work in the United States; the description also identifies a Fresno, California field assignment.
Field ServiceEquipment Field Service
No H1B Sponsorship

About the job

Requirements
  • An Associate's or Bachelor's degree in Electrical Engineering, Biomedical Engineering, Mechanical Engineering, or a related field and at least 4 years of experience servicing electrical equipment; or equivalent military education and at least 4 years of experience servicing electrical equipment; or a high school diploma or GED and at least 8 years of experience servicing electrical equipment.
  • Experience interfacing with internal team members and external customers as part of a solution-based service process.
  • Experience diagnosing and repairing mechanical, electromechanical, and/or electronic equipment.
  • Experience troubleshooting and responding to customer concerns.
  • Experience with web applications and Microsoft suite products.
  • Compliance with GEHC's standard background check, including a post-offer drug test.
  • Compliance with customer access policies during employment, including obtaining and/or providing proof of required immunizations and additional drug tests or background checks, including a federal government background check if assigned to support a federal government contract.
  • Ability to lift, carry, push, and pull up to 35 pounds unassisted and frequently bend, stoop, twist, climb, crouch/squat, and kneel/crawl.
  • Legally authorized to work in the United States.
Responsibilities
  • Perform advanced troubleshooting and repair on assigned equipment.
  • Perform installation, validation, and maintenance on assigned equipment as needed.
  • Lead, instruct, and assist less experienced Field Engineers, and provide coaching and feedback to team members.
  • Lead customer communications and serve as an escalation point for customer-related concerns, including installations.
  • Own customer issues from dispatch or identification through resolution, and proactively keep other team members informed of issue status for designated customers.
  • Lead and communicate headquarters and zone- or area-level initiatives.
  • Co-lead regular team or modality meetings as required.
  • Partner with customers and recommend value-added services to help them operate their businesses more efficiently.
  • Maintain customer service logs and internal service records in a timely manner, order repair parts, and manage cycle times.
  • Use the GEHC escalation process as needed and work with regional and national support to define and implement corrective action plans to resolve customer issues promptly.
  • Communicate and partner with teammates and colleagues.
  • Serve as a member and leader of the account community for assigned key accounts; engage commercial counterparts, identify potential sales leads, participate in opportunities such as contract renewals, and help promote and implement revenue programs.
  • Focus on customer needs and satisfaction, build and enhance customer relationships, and develop into a perceived business partner to the customer.
  • Keep up to date with competitor information and market trends.
  • Demonstrate commercial acumen and serve as a key member and leader of the account community for assigned accounts.
  • Collaborate with Commercial Sales teams and regional/zone leadership to support business growth.
  • Assist the Area Service Manager or Director of Service in creating growth and/or deployment strategies.
  • Provide application training to clinical or scientific staff on designated equipment as needed.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.